siRNA treatment lowers triglycerides in individuals along with uncommon health condition

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride amounts through 80% and decreased the threat of pancreatitis in patients with constant chylomicronemia, with or without a hereditary diagnosis.